Modulation of Neurological Deficits and Expression of Glutamate Receptors during Experimental Autoimmune Encephalomyelitis after Treatment with Selected Antagonists of Glutamate Receptors

<table>Scores of the neurological symptoms of animals during the course of  EAE. The results are means ± SD from more than 120 animals. The arrows in the diagram indicate the time point of drug administration in treated groups.</table>

BioMed Research International

fig1

Figure 1

Figure 1: Modulation of Neurological Deficits and Expression of Glutamate Receptors during Experimental Autoimmune Encephalomyelitis after Treatment with Selected Antagonists of Glutamate Receptors 

Figure 1 | Modulation of Neurological Deficits and Expression of Glutamate Receptors during Experimental Autoimmune Encephalomyelitis after Treatment with Selected Antagonists of Glutamate Receptors 